戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 International Medical Corps, and the Guinean Red Cross.
2 ated components from the blood supply of the Red Cross.
3 lyzed in plasma from a total of 600 American Red Cross adult blood donors from six locations in 2010.
4 -blind, placebo-controlled trial at the Thai Red Cross AIDS Research Centre in Bangkok, Thailand.
5  National Institutes of Health, and the Thai Red Cross AIDS Research Centre.
6                                     American Red Cross and Blood Systems, Inc. introduced new criteri
7 uring 2018-20, throughout which the DR Congo Red Cross and local authorities, with support from the I
8 support from the International Federation of Red Cross and Red Crescent Societies, provided SDB servi
9 plasma is currently marketed by the American Red Cross as a virally inactivated alternative to fresh-
10 nd 1275449 repeat blood donors at 3 American Red Cross blood centers from 1993 through 1995; and for
11                    Data were from 9 American Red Cross blood centers that routinely collect from 16-
12                               Using American Red Cross blood donor data as an example, the authors fo
13 This cross-sectional study included American Red Cross blood donors (aged >=18 years) who were survey
14 of HCV genotypes/subgenotypes among American Red Cross blood donors confirmed positive as HCV-NAT yie
15 d DNA (Central Laboratory of The Netherlands Red Cross Blood Transfusion Service [CLB] RIA).
16 of the whole blood collected by the American Red Cross, but young age and first-time donation status
17 of the whole blood collected by the American Red Cross each year.
18 cy virus and hepatitis C virus, the American Red Cross estimates the risk of transfusion-transmitted
19 leukemia virus I/II is 1:2,993,000, based on Red Cross estimates.
20 f local landrace "Vatikiotiko", "Sivan F1", "Red Cross F1" and "Creamgold" was examined.
21 ercially cultivated genotypes ("Creamgold", "Red Cross F1" and "Sivan F1").
22 pecially when comparing with "Sivan F1" and "Red Cross F1", whereas no flavonoids were detected in "V
23  the American Heart Association and American Red Cross first aid guidelines follows the completion of
24 t Nile virus testing program of the American Red Cross for 2003 and 2004 to identify geographic and t
25 ne blood donations collected by the American Red Cross from 13 December 2019 to 17 January 2020 from
26                                 The Japanese Red Cross has been evaluating the AMPLINAT MPX system si
27 , together with UNICEF and the International Red Cross, has formulated a strategy to combat the epide
28 s/coaches), and method (7% followed American Red Cross methods, 55% followed American Heart Associati
29                              A 2003 American Red Cross national donor complication database from 7,00
30    From June 2003 through 2008, the American Red Cross performed follow-up interviews with and additi
31 seroepidemiologic study was conducted in two Red Cross regions (Los Angeles and Miami) to determine t
32                          In 2006, 9 American Red Cross regions collected 145,678 whole blood donation
33  the eye camp at the 6th Station of the Thai Red Cross Society, Aranyaprathet District, Sa Kaeo, Thai
34       With the help and collaboration of the Red Cross, Study 1, a field experiment, directly assesse
35  deaths worldwide and is led by the American Red Cross, the Centers for Disease Control and Preventio
36  American Heart Association and the American Red Cross, these guidelines represent the first comprehe
37 onal blood suppliers, including the American Red Cross, who refused to sell hospitals nonleukoreduced